SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Inflazyme Pharmaceuticals (T.IZP) -- Ignore unavailable to you. Want to Upgrade?

To: Luc Richard who wrote (1283)8/20/1999 8:22:00 PM
From: Chuca Marsh  Read Replies (1) | Respond to of 1501
 
When we talked about the sheep test a few years ago now. I had that Cowens report on the efficiacy of the ...darn I lost it..the company name...not but 2/3rds as good as our percents. That company was a ten buck US IPO back then...14 $ US the first day...I think I read it went south ( the company or the Drug for Asthma) anyone...Sorry I can't remember the name...the LETTER " A" comes to me.
As a start on the name.
Chucka



To: Luc Richard who wrote (1283)8/21/1999 12:28:00 PM
From: Sean Janzen  Read Replies (2) | Respond to of 1501
 
This FDA web page shows the probability of a drug passing each phase of human clinical testing: fda.gov


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News